Rituximab Treatment for Persistent Scleritis Associated with Rheumatoid Arthritis
- 20 May 2010
- journal article
- case report
- Published by Informa UK Limited in Ocular Immunology and Inflammation
- Vol. 18 (3), 223-225
- https://doi.org/10.3109/09273941003739928
Abstract
Purpose: To report a clinical case of a patient with severe scleritis associated with rheumatoid arthritis (RA) refractive to conventional treatment that was treated effectively with rituximab. Methods and Results: A 55-year-old man with RA, on etanercept and oral methotrexate, was referred with diagnosis of acute stromal keratitis, anterior uveitis, and anterior nodular scleritis in his right eye. Cyclophosphamide induced complete regression of acute stromal keratitis and anterior uveitis, but scleritis was still active and persistent. After two 1000-mg infusions of rituximab, scleritis regressed completely and is still in remission 9 months after the second rituximab infusion, without any concomitant use of oral steroids. Conclusion: Rituximab may be a treatment alternative in severe scleritis that is refractive to conventional therapy. Considering its safety profile, further studies are needed to refine its mechanism of action, optimal indications, and dosing in ocular inflammationKeywords
This publication has 9 references indexed in Scilit:
- Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open‐label extension analysisArthritis & Rheumatism, 2007
- Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosisBritish Journal of Ophthalmology, 2007
- Etanercept (Enbrel)-Associated Inflammatory Eye Disease: Case Report and Review of the LiteratureOcular Immunology and Inflammation, 2006
- Successful treatment of Wegener's granulomatosis associated scleritis with rituximabBritish Journal of Ophthalmology, 2005
- ScleritisSurvey of Ophthalmology, 2005
- Etanercept plus Standard Therapy for Wegener's GranulomatosisNew England Journal of Medicine, 2005
- B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experienceAnnals Of The Rheumatic Diseases, 2003
- Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by MethotrexateAmerican Journal of Ophthalmology, 2003
- T Cell Activation in Rheumatoid Synovium Is B Cell DependentThe Journal of Immunology, 2001